Genesco (NYSE:GCO) Announces Quarterly Earnings Results

Genesco (NYSE:GCO) issued its quarterly earnings data on Friday. The company reported $3.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.73 by $0.01, FiscalAI reports. The business had revenue of $799.94 million during the quarter, compared to the consensus estimate of $476.67 million. Genesco updated its FY 2027 guidance to 1.900-2.300 EPS.

Here are the key takeaways from Genesco’s conference call:

• Strong Q4 execution with total comps +9%, revenue of $800M (+7%), Q4 adjusted EPS $3.74 and full-year adjusted EPS $1.45, led by Journeys (Q4 comps +12%) and 4.0 stores comping 25%+.
• Fiscal 2027 outlook targets operating income of $32M–$38M and adjusted EPS of $1.90–$2.30, with comparable sales expected +1%–2% (total sales roughly flat to down ~1% after planned closures and license exits).
• Schuh will undergo a deliberate promotional reset to restore margin discipline, which management says will drive mid-single-digit sales declines and limit near-term margin recovery despite expected improvement over the year.
• Ongoing headwinds include tariff pressure and license wind‑downs: tariffs are expected to have a net negative operating income impact of ~$5M–$10M, and Genesco Brands will see sales pressure ahead of the Wrangler launch.
• Balance sheet and capital allocation are supportive — Q4 free cash flow of $164M, year-end net cash position, $29.8M buyback capacity remaining, and planned capex $65M–$70M to accelerate the Journeys 4.0 roll-out (~80 additional 4.0s to reach ~20% of the fleet).

Genesco Price Performance

Shares of NYSE GCO opened at $26.66 on Friday. Genesco has a twelve month low of $16.19 and a twelve month high of $38.95. The company has a current ratio of 1.58, a quick ratio of 0.30 and a debt-to-equity ratio of 0.14. The company has a market capitalization of $287.66 million, a price-to-earnings ratio of -148.11 and a beta of 1.86. The firm has a 50-day moving average of $29.39 and a two-hundred day moving average of $29.62.

Institutional Trading of Genesco

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Fund 1 Investments LLC lifted its stake in Genesco by 3.5% during the fourth quarter. Fund 1 Investments LLC now owns 986,241 shares of the company’s stock valued at $24,429,000 after purchasing an additional 33,044 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in Genesco by 23.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 409,227 shares of the company’s stock worth $10,137,000 after buying an additional 76,494 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in Genesco by 50.0% in the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 300,000 shares of the company’s stock worth $7,431,000 after buying an additional 100,000 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of Genesco by 6.7% in the third quarter. Arrowstreet Capital Limited Partnership now owns 290,639 shares of the company’s stock valued at $8,426,000 after buying an additional 18,184 shares in the last quarter. Finally, Bridgeway Capital Management LLC increased its holdings in shares of Genesco by 29.7% in the second quarter. Bridgeway Capital Management LLC now owns 238,252 shares of the company’s stock valued at $4,691,000 after buying an additional 54,498 shares in the last quarter. 94.51% of the stock is currently owned by institutional investors.

Genesco News Roundup

Here are the key news stories impacting Genesco this week:

• Positive Sentiment: Q4 results beat expectations — Genesco reported non‑GAAP EPS of about $3.74 and roughly $800M in revenue, both ahead of consensus, driven by strength at Journeys. This beat is the principal near‑term catalyst cited by markets. Article Title
• Positive Sentiment: Management highlighted intensified Journeys growth initiatives and a profitability “reset” plan for the Schuh brand — commentary investors view as a credible path to margin recovery and higher long‑term returns. Article Title
• Neutral Sentiment: Full earnings package and management commentary are available — earnings call transcript, slide deck and press release give detail for investors doing a deeper read of comps, margins and capital allocation. Slide Deck / Press Release BusinessWire Release
• Negative Sentiment: FY‑2027 guidance: Genesco set EPS of $1.90–$2.30 and revenue guidance near $2.4B, which is slightly below some sell‑side revenue expectations — that revenue shortfall tempers the print and could limit upside if execution stalls. Article Title
• Neutral Sentiment: Analysts adjusted forecasts ahead of the print — some had raised expectations into the quarter, so future revisions will matter; watch how guidance and margin targets compare with updated street models. Article Title

Analyst Upgrades and Downgrades

Several research firms have commented on GCO. UBS Group set a $38.00 target price on shares of Genesco in a research note on Friday, December 5th. Truist Financial set a $38.00 price target on shares of Genesco in a research note on Wednesday, January 14th. Zacks Research upgraded shares of Genesco from a “strong sell” rating to a “hold” rating in a research note on Wednesday, January 14th. Wall Street Zen cut Genesco from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, Williams Trading upgraded Genesco to a “strong-buy” rating in a research report on Monday, January 12th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Genesco presently has an average rating of “Hold” and an average target price of $36.00.

Genesco Company Profile

Genesco Inc is a Nashville, Tennessee-based retailer, wholesaler and licensee specializing in branded footwear, headwear, apparel and accessories. Through its portfolio of retail chains, wholesale distribution channels and licensing agreements, Genesco brings a range of product offerings to consumers in North America and Europe.

The company’s retail segment includes specialty chains such as Journeys, which targets fashion-focused teens and young adults in the United States and Canada, and Schuh, a footwear retailer with locations in the United Kingdom and Ireland.